Due to its simplicity, low cost and accuracy, CRISPR-Cas9 has become a promising new technique in the field of gene editing. However, despite its virtues, it is not yet immune to scientific hazards and ethical legal concerns. These concerns have been used to justify opposition to genetic manipulation, and have led to some regulations to ban or impose a moratorium based on the precautionary principle. In Europe, regulation mostly comes from the European Union and the Council of Europe, both very cautious towards gene editing. In this article, two arguments on the future legal framework of CRISPR-Cas9 are made. The first is that continued research will contribute to more scientific accuracy; thus, the precautionary principle should promote regulated research to achieve this aim. The second is that most of the legal and ethical concerns surrounding CRISPR-Cas9 are based on unfounded prejudice emanating from a mystical understanding of the human genome.

中文翻译：

---

CRISPR-Cas9与更美好未来的承诺

由于其简单，低成本和准确性，CRISPR-Cas9已成为基因编辑领域有希望的新技术。但是，尽管有其优点，但它仍然不能幸免于科学危害和道德法律问题。这些担忧已被用来证明反对基因操纵的正当性，并导致一些法规基于预防原则禁止或施加暂停令。在欧洲，法规主要来自欧盟和欧洲委员会，它们对基因编辑都非常谨慎。在本文中，就CRISPR-Cas9的未来法律框架提出了两个论点。首先，持续的研究将有助于提高科学准确性；因此，预防原则应促进规范研究以实现这一目标。